Cargando…

Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA

Vascular endothelium plays a crucial role in vascular homeostasis and tissue fluid balance. To target endothelium for robust genome editing, we developed poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) (PEG-b-PLGA) copolymer-based nanoparticle formulated with polyethyleneimine. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xianming, Jin, Hua, Huang, Xiaojia, Chaurasiya, Birendra, Dong, Daoyin, Shanley, Thomas P., Zhao, You-Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769807/ https://www.ncbi.nlm.nih.gov/pubmed/34986352 http://dx.doi.org/10.1016/j.celrep.2021.110196

Ejemplares similares

Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing
por: Xiu, Kemao, et al.
Publicado: (2022)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

Efficient CRISPR/Cas9 Plasmids for Rapid and Versatile Genome Editing in Drosophila
por: Gokcezade, Joseph, et al.
Publicado: (2014)

Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species
por: Lombardi, Lisa, et al.
Publicado: (2019)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9
por: Agudelo, Daniel, et al.
Publicado: (2020)

Robust CRISPR/Cas9 Genome Editing of the HUDEP-2 Erythroid Precursor Line Using Plasmids and Single-Stranded Oligonucleotide Donors
por: Moir-Meyer, Gemma, et al.
Publicado: (2018)

Direct evidence of CRISPR-Cas9-mediated mitochondrial genome editing
por: Bi, Rui, et al.
Publicado: (2022)

CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
por: Cheng, Hao, et al.
Publicado: (2021)

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
por: Kazemian, Pardis, et al.
Publicado: (2022)

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
por: Sinclair, Frazer, et al.
Publicado: (2023)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

A boronic acid–rich dendrimer with robust and unprecedented efficiency for cytosolic protein delivery and CRISPR-Cas9 gene editing
por: Liu, Chongyi, et al.
Publicado: (2019)

CRISPR/Cas9: A Robust Genome-Editing Tool with Versatile Functions and Endless Application
por: Zhang, Baohong
Publicado: (2020)

In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina
por: Latella, Maria Carmela, et al.
Publicado: (2016)

Correction for Lombardi et al., “Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species”
por: Lombardi, Lisa, et al.
Publicado: (2020)

Establishment of an Integrated CRISPR/Cas9 Plasmid System for Simple and Efficient Genome Editing in Medaka In Vitro and In Vivo
por: Zhang, Zeming, et al.
Publicado: (2023)

Carboxylated branched poly(β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing
por: Rui, Yuan, et al.
Publicado: (2019)

CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta
por: Zhang, Xiaoping, et al.
Publicado: (2019)

Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells
por: Hindriksen, Sanne, et al.
Publicado: (2017)

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
por: Wilbie, Danny, et al.
Publicado: (2019)

CRISPR/Cas9-deaminase enables robust base editing in Rhodobacter sphaeroides 2.4.1
por: Luo, Yufeng, et al.
Publicado: (2020)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

CRISPR–Cas9 Based Bacteriophage Genome Editing
por: Zhang, Xueli, et al.
Publicado: (2022)

CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023)

CRISPR-Cas9 gene editing and human diseases
por: Jinka, Chaitra, et al.
Publicado: (2022)

CRISPR/Cas9 Essential Gene Editing in Drosophila
por: Osadchiy, I. S., et al.
Publicado: (2023)

High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA
por: Oh, Soyoung A., et al.
Publicado: (2022)

A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines
por: Rozen-Gagnon, Kathryn, et al.
Publicado: (2021)

Appropriate Delivery of the CRISPR/Cas9 System through the Nonlysosomal Route: Application for Therapeutic Gene Editing
por: Yin, Hang, et al.
Publicado: (2020)

Antibody-targeted chromatin enables effective intracellular delivery and functionality of CRISPR/Cas9 expression plasmids
por: Killian, Tobias, et al.
Publicado: (2019)

Targeted delivery of CRISPR-Cas9 ribonucleoprotein into arthropod ovaries for heritable germline gene editing
por: Chaverra-Rodriguez, Duverney, et al.
Publicado: (2018)

Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
por: Wei, Tuo, et al.
Publicado: (2020)

Virus-Like Particle Mediated CRISPR/Cas9 Delivery for Efficient and Safe Genome Editing
por: Lyu, Pin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o95pl53l0r3j6q61spmjfbbt03